Long-term tezacaftor/ivacaftor safety and efficacy in people with cystic fibrosis and an F508del-CFTR mutation: 96-week, open-label extension of the EXTEND trial-Reference-Cited by-同舟云学术

Long-term tezacaftor/ivacaftor safety and efficacy in people with cystic fibrosis and an F508del-CFTR mutation: 96-week, open-label extension of the EXTEND trial

Published:2022-12 Issue: Volume: Page:
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Flume Patrick A.,Harris R. Scott,Paz-Diaz Hildegarde,Ahluwalia Neil,Higgins Mark,Campbell Daniel,Berhane Indrias,Shih Judy L.,Sawicki Gregory

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference15 articles.

1. The future of cystic fibrosis care: a global perspective;Bell;Lancet Respir Med,2020

2. Progress in therapies for cystic fibrosis;De Boeck;Lancet Respir Med,2016

3. A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect;Boyle;Lancet Respir Med,2013

4. Patients with cystic fibrosis having a residual function mutation: data from the Italian registry;Salvatore;Pediatr Pulmonol,2019

5. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice;Castellani;J Cyst Fibros,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of severe pulmonary exacerbation in a young patient with cystic fibrosis in the era of CFTR modulators;International Journal of Infectious Diseases;2024-10

2. TMEM16 proteins: Ca²⁺‑activated chloride channels and phospholipid scramblases as potential drug targets (Review);International Journal of Molecular Medicine;2024-07-29

3. Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians;Current Problems in Pediatric and Adolescent Health Care;2024-06

4. Real world study on elexacaftor‐tezacaftor‐ivacaftor impact on cholesterol levels in adults with cystic fibrosis;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-01-12

5. Cystic fibrosis year in review 2022;Pediatric Pulmonology;2023-08-18